Gene · 5817
Papers4,420
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 4,420
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Platelet-mediated circulating tumor cell evasion from natural killer cell killing through immune checkpoint CD155-TIGIT. | Hepatology | 2025 | 38779918 | PubTator, text mining | PubMed |
| Immune Checkpoints Are New Therapeutic Targets in Regulating Cardio-, and Cerebro-Vascular Diseases and CD4+Foxp3+ Regulatory T Cell Immunosuppression. | Int J Drug Discov Pharm | 2024 | 39926714 | PubTator, text mining | PubMed |
| Novel pyroptosis-immune-related lncRNA signature exhibits a distinct immune cell infiltration landscape in breast cancer. | Front Immunol | 2024 | 39906743 | PubTator, text mining | PubMed |
| Single-cell RNA sequencing elucidates cellular plasticity in esophageal small cell carcinoma following chemotherapy treatment. | Front Genet | 2024 | 39850495 | PubTator, text mining | PubMed |
| The emergence of DNAM-1 as the facilitator of NK cell-mediated killing in ovarian cancer. | Front Immunol | 2024 | 39835114 | PubTator, text mining | PubMed |
| Turning Cancer Immunotherapy to the Emerging Immune Checkpoint TIGIT: Will This Break Through the Limitations of the Legacy Approach? | Vaccines (Basel) | 2024 | 39771968 | PubTator, text mining | PubMed |
| Can there be calm during a cytokine storm? Immune checkpoint pathways affecting the severity of COVID-19 disease. | Front Microbiol | 2024 | 39764446 | PubTator, text mining | PubMed |
| Identification and Validation of Epithelial Cell Centre Regulatory Transcription Factors in the Gastric Cancer Microenvironment. | Int J Gen Med | 2024 | 39759895 | PubTator, text mining | PubMed |
| METTL1 mediates PKM m7G modification to regulate CD155 expression and promote immune evasion in colorectal cancer. | J Transl Med | 2024 | 39741310 | PubTator, text mining | PubMed |
| Prognostic value of tertiary lymphoid structures in triple-negative breast cancer: integrated analysis with the tumor microenvironment and clinicopathological features. | Front Immunol | 2024 | 39723208 | PubTator, text mining | PubMed |
| [The effect of c-Myc on regulating the immune-related ligands in Y subtype small cell lung cancer through histone deacetylase 1]. | Zhonghua Zhong Liu Za Zhi | 2024 | 39622733 | PubTator, text mining | PubMed |
| Exercise: a non-drug strategy of NK cell activation. | Braz J Med Biol Res | 2024 | 39607207 | PubTator, text mining | PubMed |
| SOCS1 Inhibits IL-6-Induced CD155 Overexpression in Lung Adenocarcinoma. | Int J Mol Sci | 2024 | 39596207 | PubTator, text mining | PubMed |
| Targeting the immune privilege of tumor-initiating cells to enhance cancer immunotherapy. | Cancer Cell | 2024 | 39515328 | PubTator, text mining | PubMed |
| Myeloid subsets impede the efficacy of anti-PD1 therapy in patients with advanced gastric cancer (WJOG10417GTR study). | J Immunother Cancer | 2024 | 39489543 | PubTator, text mining | PubMed |
| Single-cell and spatial transcriptome characterize coinhibitory cell-cell communications during histological progression of lung adenocarcinoma. | Front Immunol | 2024 | 39474422 | PubTator, text mining | PubMed |
| Iron-loaded cancer-associated fibroblasts induce immunosuppression in prostate cancer. | Nat Commun | 2024 | 39426954 | PubTator, text mining | PubMed |
| Effect of plasma-induced oxidation on NK cell immune checkpoint ligands: A computational-experimental approach. | Redox Biol | 2024 | 39395241 | PubTator, text mining | PubMed |
| Prospective Molecular Targets for Natural Killer Cell Immunotherapy against Glioblastoma Multiforme. | Cells | 2024 | 39329751 | PubTator, text mining | PubMed |
| The Interactions of T Cells with Myeloid-Derived Suppressor Cells in Peripheral Blood Stem Cell Grafts. | Cells | 2024 | 39329729 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5817/papers?page=19